Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1228 | 1039 | 1259 | 1400 | 1864 | 2761 |
Fund Return | 22.75% | 3.87% | 25.95% | 11.86% | 13.27% | 10.69% |
Place in category | 158 | 494 | 151 | 56 | 9 | 5 |
% in Category | 33 | 94 | 39 | 9 | 2 | 2 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Div incm Sel InvPlus F | 1.17B | 19.40 | 3.62 | 9.61 | ||
Manulife RetPlus Div incm | 1.17B | 17.95 | 2.25 | 8.23 | ||
Manulife Dividend Income GIF 2 | 1.17B | 17.68 | 1.99 | 7.96 | ||
Manulife Div incm Sel Original 75 | 1.17B | 18.23 | 2.51 | 8.51 | ||
Manulife RetPlus Div incm F | 1.17B | 19.03 | 3.28 | 9.32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Canadian Growth Comp Sr A | 12.54B | 38.00 | 11.80 | 13.95 | ||
Fidelity Canadian Growth Comp Sr F | 12.54B | 39.75 | 13.34 | 15.51 | ||
Fidelity Canadian Growth Comp Sr B | 12.54B | 38.29 | 12.05 | 14.19 | ||
Fidelity Canadian Large Cap Sr F | 8.65B | 17.58 | 14.28 | 9.97 | ||
Fidelity Canadian Large Cap Sr F5 | 8.65B | 17.59 | 14.29 | 9.98 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 4.25 | 438.72 | +0.80% | |
Canadian Natural | CA1363851017 | 3.81 | 43.52 | +0.81% | |
TMX Group | CA87262K1057 | 3.60 | 44.43 | +0.14% | |
Elevance Health | US0367521038 | 3.57 | 372.71 | +0.49% | |
Norfolk Southern | US6558441084 | 3.52 | 237.63 | +0.79% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Strong Sell | BUY | Strong Buy |
Summary | Strong Sell | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review